IDXX 151.39 Idexx Laboratories $IDXX Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 12:46 PM

IDXX 151.39 Idexx Laboratories $IDXX Hit a 52 week high of 152.08 Closing the day 09:44 at 151.39 -1.11 -0.73% With a day low of 150.97 and a total volume of 21,784.

IDXX Recent Posts: http://investorshangout.com/IDEXX-Laboratorie...DXX-54421/

IDXX Idexx Laboratories Recent Headline News

Exactech (EXAC) Down to Strong Sell On Dismal Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 12:30PM CST
Exactech Inc.'s (EXAC) lackluster third-quarter 2014 results (reported on Oct 21), with both earnings and revenues missing expectations, have set a negative earnings estimate revision trend for the company.
ICUI: 85.97 (+1.02), BABY: 33.73 (-0.58), EXAC: 22.35 (-0.12), IDXX: 150.81 (-1.69)

Uptrend Call Working As Idexx Laboratories Stock Rises 24.1% (IDXX)
Comtex SmarTrend(R) - Wed Nov 12, 9:56AM CST
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on October 21st, 2014 at $122.52. In approximately 3 weeks, Idexx Laboratories has returned 24.07% as of today's recent price of $152.00.
IDXX: 150.81 (-1.69)

Trade-Ideas: Idexx Laboratories (IDXX) Is Today's Strong And Under The Radar Stock
at The Street - Tue Nov 11, 9:42AM CST
Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a strong and under the radar candidate
IDXX: 150.81 (-1.69)

SmarTrend Watching for Potential Pullback in Shares of Idexx Laboratories After 1.39% Gain
Comtex SmarTrend(R) - Mon Nov 10, 5:17PM CST
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $144.18 to a high of $147.67. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $146.00 on volume of 560,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 150.81 (-1.69)

Idexx Laboratories Earnings Hindsight: Up 7.4% in Last 17 Days (IDXX)
Comtex SmarTrend(R) - Mon Nov 10, 1:31PM CST
17 days ago, on October 24th, 2014, Idexx Laboratories (NASDAQ:IDXX) reported its earnings. Analysts, on average, expected earnings of $0.86 per share on sales of $371.3 million. Idexx Laboratories actually reported earnings of $1.05 per share on sales of $383.5 million, beating EPS estimates by $0.19 and beating revenue estimates by $12.2 million. Since the company's report, shares of Idexx Laboratories have risen from $135.20 to $145.16, representing a gain of 7.4% in the past 17 days.
IDXX: 150.81 (-1.69)

Idexx Laboratories Has Returned 17.5% Since SmarTrend Recommendation (IDXX)
Comtex SmarTrend(R) - Wed Nov 05, 9:25AM CST
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on October 21st, 2014 at $122.52. In approximately 2 weeks, Idexx Laboratories has returned 17.52% as of today's recent price of $143.98.
IDXX: 150.81 (-1.69)

Comparing America's 3 Largest Diagnostic Substances Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 03, 12:03PM CST

QDEL: 28.25 (-0.09), NEOG: 42.99 (-1.06), IDXX: 150.81 (-1.69)

Quarterly Earnings Releases and Recognitions - Research Reports on GlaxoSmithKline, IDEXX, BioMarin, GE and Lockheed Martin
PR Newswire - Wed Oct 29, 8:30AM CDT
Today, Analysts Review released its research reports regarding GlaxoSmithKline plc (NYSE: GSK), IDEXX Laboratories, Inc. (NASDAQ: IDXX), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), General Electric Company (NYSE: GE) and Lockheed Martin Corporation (NYSE: LMT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7542-100free.
LMT: 186.43 (-1.54), GE: 26.44 (+0.02), BMRN: 84.08 (-3.84), IDXX: 150.81 (-1.69), GSK: 45.70 (+0.04), NVS: 93.99 (-0.39)

IDEXX Laboratories (IDXX) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 7:57AM CDT
IDEXX Laboratories (IDXX) Shares March Higher, Can It Continue?
IDXX: 150.81 (-1.69)

IDEXX Tops Q3 Earnings and Revenues; Guidance Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:10PM CDT
Since the news release, IDEXX's (IDXX) share price has climbed 9.8% to eventually close at $138.76 yesterday.
ATEC: 1.38 (+0.02), EW: 124.27 (-0.28), IDXX: 150.81 (-1.69), ANGO: 16.67 (-0.19)

Today's Strong And Under The Radar Stock Is Idexx Laboratories (IDXX)
at The Street - Tue Oct 28, 8:51AM CDT
Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a strong and under the radar candidate
IDXX: 150.81 (-1.69)

IDEXX Laboratories, Inc. Is as Fit as a Butcher's Dog
Brian Orelli, The Motley Fool - Motley Fool - Fri Oct 24, 6:56PM CDT
Shares of IDEXX Laboratories jumped 7% today after reporting a solid third quarter, raising 2014 guidance, and issuing 2015 guidance that looks even better. The stock of the animal health-test provider soared to a 52-week and all-time high. ...
IDXX: 150.81 (-1.69)

Idexx Laboratories Set to Possibly Pullback After Yesterday's Rally of 7.00%
Comtex SmarTrend(R) - Fri Oct 24, 4:12PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $130.06 to a high of $140.42. Yesterday, the shares gained 7.0%, which took the trading range above the 3-day high of $126.42 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 150.81 (-1.69)

IDEXX Laboratories' (IDXX) CEO Jon Ayers on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 24, 1:02PM CDT

IDXX: 150.81 (-1.69)

Idexx Q3 income up 14%
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 10:00AM CDT

IDXX: 150.81 (-1.69)

Idexx beats Street 3Q forecasts
Automated Insights - Fri Oct 24, 6:27AM CDT
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported net income of $52.1 million in its third quarter.
IDXX: 150.81 (-1.69)

IDEXX Laboratories beats by $0.15, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 6:07AM CDT

IDXX: 150.81 (-1.69)

IDEXX Laboratories Announces Third Quarter Results
PR Newswire - Fri Oct 24, 6:00AM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) today reported that revenues for the third quarter of 2014 increased 13% versus the prior year period to $384 million. Organic revenue growth1 for the third quarter of 2014 versus the prior year period was also 13%, or 11% normalized for changes in distributor inventory2. Earnings per diluted share ("EPS"

for the quarter ended September 30, 2014 increased 21% from the prior year period to $1.03. Adjusted EPS3 for the quarter was $1.05.
IDXX: 150.81 (-1.69)

Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 4:30PM CDT

WYN: 79.71 (-0.39), SFE: 19.33 (-0.04), F: 15.10 (+0.17), OCR: 69.38 (+0.18), B: 37.31 (+0.25), SXC: 22.48 (-0.16), VTR: 68.69 (-0.82), UPS: 107.01 (-0.78), DLPH: 70.78 (+0.07), CHH: 52.62 (-0.53), LYB: 88.39 (+0.45), COG: 33.30 (+0.60), SHPG: 202.07 (-0.35), TCB: 15.93 (-0.01), AVY: 47.79 (-0.30), AAN: 27.32 (-0.19), MGLN: 61.08 (-0.37), STT: 76.35 (-0.13), FNFG: 8.08 (+0.27), IMGN: 9.27 (-0.19), EDU: 22.11 (+0.02), BMY: 57.72 (-0.08), DTE: 79.93 (+0.15), LEA: 93.30 (-0.07), MCO: 100.88 (-0.02), FLIR: 32.30 (-0.14), IMS: 24.73 (-0.02), LPNT: 64.22 (-0.03), ERIC: 12.08 (+0.02), PG: 88.50 (-0.10), IDXX: 150.81 (-1.69), WBC: 100.80 (-0.29), NDAQ: 43.90 (+0.11), CL: 67.88 (-0.41)

Oracle Enterprise Manager Enables Seamless IT Management and Visibility for IDEXX Laboratories
Marketwired - Wed Oct 15, 7:04AM CDT
Oracle (NYSE: ORCL)
IDXX: 150.81 (-1.69), ORCL: 40.71 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bud Ecosystem Debuts AIOS, Aims to Slash Costs

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Guaranteed Roof Expands with EM Exteriors through LB Capital

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Beetles Gel Polish Unveils Vibrant Fall Nail Carnival

Beetles Gel Polish Launches Fall Nail Carnival Here comes a new twist on fall fashion, and no, it ain’t your grandma's knitted sweater. We're talking nail polish—a vibrant, flashy ordeal brought to you by Beetles Gel Polish with their Fall Nail Carnival. They're rolling out this spectacle not just for your visions of grandeur nail ideas, but for those seeking deals...

Linkind's Light Stick Revolutionizes Retail Lighting Experience

Transforming Lighting in Retail Spaces Folks, let's talk lighting. Not the humdrum switch-you-on kind, but something much snazzier, more customized, and downright interactive. I'm talking about Linkind's latest brainchild—the Smart Light Stick. Launched amidst the neon rush of tm:rw in New York City, this gizmo isn't just another bulb in the home improvement aisle. It's...

Chad Tucker's Sequel Explores Deep Spiritual Themes

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Celebrating Appalachian Soul with Aristotle Jones

Igniting a Celebration of Appalachian Soul Now here's a sound that hits you right in the gut. Aristotle Jones, known out there as the 'Appalachian Soul Man,' is making a big move. He's laying out the plan to make July the Appalachian Soul Month. This fellow isn't shy about celebrating the deep roots of Appalachian music, dropping his album Appalachian Soul Power and a new...

Andover Audio's FreePlay: Stereo Sound Goes Portable

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Piedmont Orthopedics Expands Care in Henry County

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

EnGenius Names Experienced VP to Boost Sales Growth

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...